Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S062000, C546S047000, C514S280000
Reexamination Certificate
active
10770126
ABSTRACT:
Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds, and processes for the production thereof, pharmaceutical compositions containing these compounds and the use thereof in treatment methods and for the production of pharmaceutical preparations for specific indications, in particular for the treatment of pain.
REFERENCES:
patent: 0386839 (1997-01-01), None
patent: WO-9834111 (1998-08-01), None
patent: WO-9842673 (1998-10-01), None
patent: WO-9964411 (1999-12-01), None
patent: WO-0158875 (2001-08-01), None
E. Borrione et al. “Synthesis and Cycloaddition Reactions of Ethyl Glyoxylate Imines . . . ”J. Heterocycl. Chem.(1988) 25:1831-1835.
R.W. Carling et al. “2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor”J. Med. Chem.(1992) 35(11):1942-1953.
International Search Report.
Bloms-Funke Petra
Englberger Werner Guenter
Gerlach Matthias
Jagusch Utz-Peter
Maul Corinna
Aulakh Charanjit S.
Crowell & Moring LLP
Gruenenthal GmbH
LandOfFree
Substituted 5,6,6a,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 5,6,6a,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5,6,6a,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3783789